Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

October 31, 2026

Conditions
Restless Leg DisorderRestless Leg Syndrome (RLS)PregnancySleep Disorder (Disorder)
Interventions
DEVICE

Peroneal Nerve Stimulation (PNS) Device

The TOMAC™ system is a non-invasive, wearable peroneal nerve stimulator that delivers high-frequency electrical stimulation to the common peroneal nerves at the fibular head. It is FDA-cleared for the treatment of moderate-to-severe Restless Legs Syndrome (RLS) in adults but has not been studied in pregnancy. In this trial, pregnant participants will undergo an in-clinic titration session with uterine contraction and fetal monitoring at ≥28 weeks' gestation to determine comfortable therapeutic intensity. They will then use the device at home for 8 weeks, up to four 30-minute sessions daily, prioritizing periods of high symptom burden or before bedtime. Outcomes will assess feasibility, acceptability, adherence, symptom improvement, sleep quality, and maternal-fetal safety.

Trial Locations (2)

02903

NOT_YET_RECRUITING

Rhode Island Hospital, Providence

RECRUITING

Rhode Island Hospital, Providence

All Listed Sponsors
collaborator

American College of Chest Physicians

OTHER

lead

Rhode Island Hospital

OTHER

NCT07144631 - Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome | Biotech Hunter | Biotech Hunter